(1R)-1,2-dimethyl-1,3-dihydroisoindole

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: (1R)-1,2-dimethyl-1,3-dihydroisoindole
• 化学式: C₁₀H₁₃N
• 分子量: 147.22
• InChiKey: RXVIXMALGSJUJF-MRVPVSSYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• DIHYDROPTERIDINONES I
  申请人：Boehringer Ingelheim International GmbH

  公开号：US20130225549A1

  公开（公告）日：2013-08-29

  The present invention relates to dihydropteridinones, their use as modulators of γ-secretase and to pharmaceutical compositions containing said compounds. In particular, the present invention relates to compounds which interfere with γ-secretase and/or its substrate and therefore modulate the formation of Aβ peptides.

  本发明涉及二氢喜树碱酮，它们作为γ-分泌酶调节剂的用途以及含有该化合物的药物组合物。具体而言，本发明涉及干扰γ-分泌酶和/或其底物的化合物，因此调节Aβ肽的形成。
• ANTIVIRAL COMPOUNDS
  申请人：Guo Hongyan

  公开号：US20130137877A1

  公开（公告）日：2013-05-30

  The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

  这项发明涉及抗病毒化合物、含有这些化合物的组合物、包括给予这些化合物的治疗方法，以及用于制备这些化合物的过程和中间体。
• Caspase inhibitor prodrugs
  申请人：Durrant Steven

  公开号：US20070155718A1

  公开（公告）日：2007-07-05

  This invention relates to prodrugs of caspase inhibitors comprising of a furo[3,2-d]oxazolin-5-one moiety which, under specific conditions, can convert into biologically active compounds, particularly caspase inhibitors. This invention also relates to the processes for preparing these prodrugs of caspase inhibitors. This invention further relates to pharmaceutical compositions comprising said prodrugs and to the use thereof for the treatment of diseases related to inflammatory or degenerative conditions.
• US8088368B2
  申请人：——

  公开号：US8088368B2

  公开（公告）日：2012-01-03
• US8575118B2
  申请人：——

  公开号：US8575118B2

  公开（公告）日：2013-11-05